Asia Pacific Lithotripsy Market
The Asia Pacific lithotripsy market was valued at US$ 235.12 million in 2023 and is expected to reach US$ 419.89 million by 2031; it is estimated to register a CAGR of 7.5% from 2023 to 2031. Rise in Mobile Lithotripsy Services Fuels Asia Pacific Lithotripsy Market
Mobile lithotripsy medical units, commercial tractor-trailers, and coaches are significantly beneficial to patients. These units offer patients a new healthcare service without any requirement to set up a specialized lithotripsy center or additional investment. Patients' experience with mobile lithotripsy services is significantly improving with technological advancements. For example, in June 2021, Mobile Medical announced launching its new state-of-the-art mobile lithotripsy unit. The lithotripter device was successfully removed from the existing lithotripsy center and installed in a cab/mobile truck. Similarly, The Oklahoma Mobile Lithotripsy Associates (OMLA), a subsidiary of Oklahoma Lithotripter Associates, has continued to provide extracorporeal shockwave lithotripsy (ESWL) services to area hospitals through a lithotripsy bus/trailer since 1995. The service began with a single Dornier unit. However, with a rise in technological advancements, the units are now transported to each location in small vans, making accessibility and scheduling noninvasive lithotripsy procedures much more accessible. Currently, mobile lithotripsy service is only available in developed countries, particularly in the US, and is anticipated to grow in other countries in the future if awareness about mobile lithotripsy service is increased worldwide. Thus, the rise in mobile lithotripsy services is anticipated to create lucrative opportunities for the lithotripsy service providers in the market in the coming years.Asia Pacific Lithotripsy Market Overview
According to the AME Publishing Company report, urolithiasis is one of the most prevalent diseases in China, with patients suffering from upper urinary stones. With high prevalence and recurrence rates, urolithiasis represents a major burden on the healthcare system in the country. Therefore, with the rising prevalence of urolithiasis, there is a high demand for extracorporeal shockwave lithotripsy (ESWL). ESWL is an advanced treatment device that has been widely adopted by doctors and patients in hospitals. Additionally, there are many hospitals in China where more than 5,000 cases annually have been treated with urolithiasis, as per the Chinese Medical Association Publishing House report. Furthermore, in a few hospitals, over 10 cases were treated in one day, and ~3,000 cases every year. Therefore, the rising prevalence of urolithiasis and the high adoption of lithotripsy in hospitals are a few factors responsible for the market growth in China.
Asia Pacific Lithotripsy Market Revenue and Forecast to 2031 (US$ Million)
Strategic insights for the Asia Pacific Lithotripsy provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Asia Pacific Lithotripsy refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
Get more information on this report Asia Pacific Lithotripsy Strategic Insights
Get more information on this report Asia Pacific Lithotripsy Report Scope
Report Attribute
Details
Market size in 2023
US$ 235.12 Million
Market Size by 2031
US$ 419.89 Million
Global CAGR (2023 - 2031)
7.5%
Historical Data
2025-2031
Forecast period
2021-2023
Segments Covered
By Product Type
By Application
By End User
Regions and Countries Covered
Asia Pacific
Market leaders and key company profiles
Get more information on this report Asia Pacific Lithotripsy Regional Insights
Get more information on this report
Asia Pacific Lithotripsy Market Segmentation
The Asia Pacific lithotripsy market is categorized into product type, application, end user, and country.
By product type, the Asia Pacific lithotripsy market is segmented into extracorporeal shock wave lithotripsy devices and intracorporeal lithotripsy devices, and ureteroscopic. The extracorporeal shock wave lithotripsy devices segment held the largest share of the Asia Pacific lithotripsy market share in 2023.
In term of application, the Asia Pacific lithotripsy market is segmented into kidney stones, ureteral stones, pancreatic stones, bile duct stones, and bladder stones. The kidney stones segment held the largest share of the Asia Pacific lithotripsy market share in 2023.
Based on end user, the Asia Pacific lithotripsy market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the Asia Pacific lithotripsy market share in 2023.
Based on country, the Asia Pacific lithotripsy market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China segment held the largest share of Asia Pacific lithotripsy market in 2023.
Becton Dickinson and Co, Boston Scientific Corp, Cook Medical Holdings LLC, DirexGroup, Dornier MedTech, Edap Tms SA, ELMED Medical Systems, EMS Electro Medical Systems SA (EMS+), Karl Storz SE & Co KG, NOVAmedtk, Olympus Corp, and Potent Medical are some of the leading companies operating in the Asia Pacific lithotripsy market.
The Asia Pacific Lithotripsy Market is valued at US$ 235.12 Million in 2023, it is projected to reach US$ 419.89 Million by 2031.
As per our report Asia Pacific Lithotripsy Market, the market size is valued at US$ 235.12 Million in 2023, projecting it to reach US$ 419.89 Million by 2031. This translates to a CAGR of approximately 7.5% during the forecast period.
The Asia Pacific Lithotripsy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Lithotripsy Market report:
The Asia Pacific Lithotripsy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Lithotripsy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Lithotripsy Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Lithotripsy Market
